Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017
September 12, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
CESCA Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 05, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Participate in the CAR-TCR Summit 2017
August 31, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN Ltd.
August 24, 2017 11:09 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Announces Issuance of New Cellular Processing Patent Poised to Revolutionize CAR-T Cell Manufacturing
July 28, 2017 07:00 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., July 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing, today announced that the U.S. Patent and Trademark...
Cesca Therapeutics Acquires the Cell Processing Systems of SynGen Under Asset Acquisition Agreement
July 10, 2017 07:45 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics Set to Join Russell Microcap® Index
June 23, 2017 09:59 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 23, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, is...
Cesca Therapeutics to Present at the 2017 Marcum MicroCap Conference
June 12, 2017 12:59 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017
May 18, 2017 08:33 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update
May 11, 2017 16:15 ET
|
Cesca Therapeutics Inc.
RANCHO CORDOVA, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...